openPR Logo
Press release

Inflammatory Bowel Disease Treatment Market: Booming Growth, CAGR of 10.1%, Key Drivers, and Upcoming Trends

Inflammatory Bowel Disease Treatment Market

Inflammatory Bowel Disease Treatment Market

The rising prevalence of Inflammatory Bowel Disease and our advances in personalized treatment will shape the landscape of the global Inflammatory Bowel Disease Treatment market in coming years.

What Is The Projected Market Size Of The Global Inflammatory Bowel Disease Treatment Market And Its Growth Rate?
The Inflammatory bowel disease treatment market has shown considerable growth due to increased awareness and treatment advancements.
• The market worth will rise from $25.26 billion in 2024 to $27.45 billion in 2025 at a CAGR of 8.6%.
• The market is projected to grow to $40.27 billion in 2029 at a CAGR of 10.1%.

What Is Driving The Growth In The Inflammatory Bowel Disease Treatment Market?
The primary driver of the inflammatory bowel disease treatment market is the rising prevalence of Crohn's disease and ulcerative colitis. These diseases are leading to a marked increase in the demand for treatments, given their widespread use in reducing bowel inflammation and preventing medical complications. As per the research published in March 2022 in the United States National Library of Medicine, around 1.6 million Americans currently suffer from inflammatory bowel disease with around 70,000 new cases diagnosed every year in the USA.

Request A Free Sample Copy:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5659&type=smp

Who Are the Key Players Driving The Inflammatory Bowel Disease Treatment Market Growth?
The key players making significant advancements are
• AbbVie Inc.
• Biogen Inc.
• Johnson & Johnson
• Amgen Inc.
• Advanced Gastroenterology and Surgery Associates P. A.
• Atlanta Gastroenterology Associates LLC
• Boehringer Ingelheim International GmbH
• Bristol-Myers Squibb Company
• Cedars-Sinai Medical Center
• Celgene Corporation
• Cleveland Clinic Foundation
• Digestive Disease Associates of Rockland P. C.
• Eli Lilly and Company
• Gastrointestinal Specialists Inc.
• Gilead Sciences Inc.
• GlaxoSmithKline plc
• Illinois Gastroenterology Group LLC
• The Johns Hopkins Hospital Inc.
• Massachusetts General Hospital
• Mayo Clinic
• Merck & Co. Inc.
• Mount Sinai Health System Inc.
• Novartis International AG
• Pfizer Inc.
• F. Hoffmann-La Roche Ltd
• Takeda Pharmaceutical Company Limited
• Texas Digestive Disease Consultants P. A.
• The Oregon Clinic - Gastroenterology West P. C.

What Are The Key Trends In The Inflammatory Bowel Disease Treatment Market?
A Few trends influencing the market are:
- Increasing number of product launches and approvals.
- Personalized dosing and treatment plans in IBD management.
- Use of telemedicine for remote monitoring of IBD patients.
- Exploration of microbiome-based therapies for IBD.
- Adoption of value-based care models in IBD treatment.

What Are The Segments Of The Global Inflammatory Bowel Disease Treatment Market?
The market is segmented by:
1) Drug Class: Aminosalicylates, Corticosteroids, TNF inhibitors, IL inhibitors, Anti-integrin, JAK inhibitors, Other Drug Classes
2) Type: Crohn's Disease, Ulcerative Colitis
3) Route Of Administration: Oral, Injectable
4) Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Which Region Leads The Inflammatory Bowel Disease Treatment Market?
North America leads the inflammatory bowel disease treatment market while Asia-Pacific is expected to be the fastest-growing region in the upcoming years. The regions covered in the Inflammatory Bowel Disease Treatment Market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Pre-book the report for swift delivery:
https://www.thebusinessresearchcompany.com/report/industrial-water-treatment-chemicals-global-market-report

What Is Covered In The Inflammatory Bowel Disease Treatment Market Global Market Report?
- Market Size Analysis: Analyze the Inflammatory Bowel Disease Treatment Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Inflammatory Bowel Disease Treatment Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Inflammatory Bowel Disease Treatment Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Inflammatory Bowel Disease Treatment Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Inflammatory Bowel Disease Treatment Market: Booming Growth, CAGR of 10.1%, Key Drivers, and Upcoming Trends here

News-ID: 3817176 • Views:

More Releases from The Business research company

Company Registration Service Market Landscape 2025: Forecast Data and Growth Strategy Insights
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Company Registration Service Market Through 2025? The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecasts, and Growth Drivers
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025? In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market in 2025: Advancement In Digital Insurance Platforms Transforms Small And Medium Enterprises Coverage With Integrated, Data-Driven Solutions
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025? The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due To Rising Environmental Monitoring Requirements: Strengthening the Growth Trajectory of the Combustion Emissions Analyzer Market
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025? In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth

All 5 Releases


More Releases for Disease

Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research. Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight: Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and